The world's largest asset manager moves its European factor investing range from tracking MSCI indexes to STOXX indexes.

The Bank of Japan (BOJ) increased its policy rate by 25 basis points to 0.5% on Jan. 24, 2025, marking the highest level since 2008. This decision aligns with a CNBC survey conducted from Jan. 15-20, ...

The Invesco Fundamental High Yield Corporate Bond ETF (PHB) made its debut on 11/15/2007, and is a smart beta exchange traded fund that provides broad exposure to the High-Yield/Junk Bond ETFs ...

The U.S. stock market closed higher Thursday, bringing the year-to-date gain of the SPDR S&P 500 ETF Trust SPY to 4%. The S&P 500 climbed 0.5% on Thursday to a record high, lifted by a broad rally ...

MassMutual Private Wealth & Trust FSB increased its stake in shares of iShares Core Dividend Growth ETF (NYSEARCA:DGRO – Free ...

MassMutual Private Wealth & Trust FSB acquired a new stake in iShares ESG Advanced MSCI USA ETF (NASDAQ:USXF – Free Report) during the fourth quarter, according to its most recent disclosure with the ...

Cullen/Frost Bankers (CFR) stands out among regional banks with low funding costs, strong deposit growth, and asset ...

The gap was even bigger if you measure it not simply over the calendar year, but over the period between the publication of MarketWatch's article on Jan. 16, 2024, and today. During that stretch, the ...

U.S. investors looking at global index funds might start singing the 1985 song referenced above. American stocks now account for three-quarters of the MSCI World index’s allocation. Topdown Charts’ ...

Some dividend ETFs only invest in stocks within sectors for both risk and return reasons. Among these, Invesco KBW High Dividend Yield Financial ETF ( KBWD) has the highest dividend yield, at 12.35%.

Gold prices surged to near three-month highs this week, with spot gold reaching $2,755.2 per ounce on Jan. 22, just below its record peak.

The biotech scene can be seen as fairly risky for new investors who want to put money to work. After all, it’s really tough to gauge which innovative biotech firms will have something genuinely ground ...